collected by :Haron Adler
referring to Today's stock marketIndex Percentage Change Point Change Dow 0.32% 79.40 S&P 500 0.22% 6.07The financial sector led the market, with the Financial Select Sector SPDR ETF (NYSEMKT: XLF) rising 1.6%. As for individual stocks, United Continental Holdings (NYSE: UAL) gained altitude after the company beat profit expectations, and Cara Therapeutics (NASDAQ: CARA) fell following the announcement of a secondary offering. Cara Therapeutics announces a secondary offeringShares of Cara Therapeutics dropped 8.2% after the biotech announced a secondary offering of its stock. Cara Therapeutics is developing Korsuva, a drug for pruritus, or severe itching, and the proceeds will be used to advance its research and clinical programs. Vifor will have the right to market Korsuva under license for that indication outside the U.S., Japan, and South Korea.

referring to Today's stock marketIndex Percentage Change Point Change Dow 0.32% 79.40 S&P 500 0.22% 6.07The financial sector led the market, with the Financial Select Sector SPDR ETF (NYSEMKT: XLF) rising 1.6%. As for individual stocks, United Continental Holdings (NYSE: UAL) gained altitude after the company beat profit expectations, and Cara Therapeutics (NASDAQ: CARA) fell following the announcement of a secondary offering. Cara Therapeutics announces a secondary offeringShares of Cara Therapeutics dropped 8.2% after the biotech announced a secondary offering of its stock. Cara Therapeutics is developing Korsuva, a drug for pruritus, or severe itching, and the proceeds will be used to advance its research and clinical programs. Vifor will have the right to market Korsuva under license for that indication outside the U.S., Japan, and South Korea.
Comments
Post a Comment